Detection of Variants With Reduced Baloxavir Marboxil Susceptibility After Treatment of Children With Influenza A During the 2018-2019 Influenza Season

被引:27
|
作者
Sato, Masatoki [1 ]
Takashita, Emi [2 ]
Katayose, Masahiko [3 ]
Nemoto, Kenji [4 ]
Sakai, Nobuko [5 ]
Hashimoto, Koichi [1 ]
Hosoya, Mitsuaki [1 ]
机构
[1] Fukushima Med Univ, Dept Pediat, 1 Hikarigaoka, Fukushima 9601295, Japan
[2] Natl Inst Infect Dis, Influenza Virus Res Ctr, Tokyo, Japan
[3] Nanohana Kids Clin, Soma, Japan
[4] Nemoto Kids Clin, Shirakawa, Japan
[5] Jin Kids Clin, Koriyama, Fukushima, Japan
基金
日本学术振兴会;
关键词
antiviraltherapy; baloxavir; influenza; oseltamivir; resistance; ADULTS;
D O I
10.1093/infdis/jiaa061
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
During the 2018-2019 influenza seasons, we detected reduced baloxavir marboxil (baloxavir) susceptible variants with I38S or I38T amino acid substitutions on the PA subunit of influenza virus ribonucleic acid polymerase in 7 of 18 baloxavi-treated children and found that virus titer rebounded in some of these children with variants. We also found fever durations to be similar between patients with or without the variants, but the patients with variants shed the virus 3 days longer and took longer to improve clinical symptoms than those without variants. The emergence of these variants should be monitored during future influenza seasons.
引用
收藏
页码:121 / 125
页数:5
相关论文
共 50 条
  • [1] Detection of Variants With Reduced Baloxavir Marboxil and Oseltamivir Susceptibility in Children With Influenza A During the 2019-2020 Influenza Season
    Sato, Masatoki
    Takashita, Emi
    Katayose, Masahiko
    Nemoto, Kenji
    Sakai, Nobuko
    Fujisaki, Seiichiro
    Hashimoto, Koichi
    Hosoya, Mitsuaki
    JOURNAL OF INFECTIOUS DISEASES, 2021, 224 (10) : 1735 - 1741
  • [2] Duration of fever and symptoms in children after treatment with baloxavir marboxil and oseltamivir during the 2018-2019 season and detection of variant influenza a viruses with polymerase acidic subunit substitutions
    Saito, Reiko
    Osada, Hidekazu
    Wagatsuma, Keita
    Chon, Irina
    Sato, Isamu
    Kawashima, Takashi
    Saito, Tadashi
    Kodo, Naoki
    Ono, Yasuhiko
    Shimada, Yasushi
    Phyu, WintWint
    Shobugawa, Yugo
    ANTIVIRAL RESEARCH, 2020, 183
  • [3] Association Between Baloxavir Marboxil Prescription for Children with Influenza B Infections and Short-Term Healthcare Consumption in Japan During the 2018-2019 Influenza Season
    Shinno, Kazuma
    Takeuchi, Masato
    Kawakami, Koji
    JOURNAL OF THE PEDIATRIC INFECTIOUS DISEASES SOCIETY, 2022, 11 (07) : 310 - 315
  • [4] Effects of Influenza Vaccination in the United States During the 2018-2019 Influenza Season
    Chung, Jessie R.
    Rolfes, Melissa A.
    Flannery, Brendan
    Prasad, Pragati
    O'Halloran, Alissa
    Garg, Shikha
    Fry, Alicia M.
    Singleton, James A.
    Patel, Manish
    Reed, Carrie
    CLINICAL INFECTIOUS DISEASES, 2020, 71 (08) : E368 - E376
  • [5] Oseltamivir Treatment for Influenza During the Flu Season of 2018-2019: A Longitudinal Study
    Li, Xiao-Guang
    Chen, Jing
    Wang, Wei
    Lin, Fei
    Li, Lu
    Liang, Jing-Jin
    Deng, Zhong-Hua
    Zhang, Bi-Ying
    Jia, Ying
    Su, Yuan-Bo
    Kang, Yong-Feng
    Du, Juan
    Liu, Ya-Qiong
    Xu, Jie
    Lu, Qing-Bin
    FRONTIERS IN MICROBIOLOGY, 2022, 13
  • [6] Baloxavir marboxil susceptibility of influenza viruses from the Asia-Pacific, 2012-2018
    Koszalka, Paulina
    Tilmanis, Danielle
    Roe, Merryn
    Vijaykrishna, Dhanasekaran
    Hurt, Aeron C.
    ANTIVIRAL RESEARCH, 2019, 164 : 91 - 96
  • [7] Characterization of influenza virus variants induced by treatment with the endonuclease inhibitor baloxavir marboxil
    Omoto, Shinya
    Speranzini, Valentina
    Hashimoto, Takashi
    Noshi, Takeshi
    Yamaguchi, Hiroto
    Kawai, Makoto
    Kawaguchi, Keiko
    Uehara, Takeki
    Shishido, Takao
    Naito, Akira
    Cusack, Stephen
    SCIENTIFIC REPORTS, 2018, 8
  • [8] Characterization of contemporary influenza B recombinant viruses harboring mutations of reduced susceptibility to baloxavir marboxil, in vitro and in mice
    Abed, Yacine
    Fage, Clement
    Checkmahomed, Liva
    Venable, Marie-Christine
    Boivin, Guy
    ANTIVIRAL RESEARCH, 2020, 179
  • [9] Sensitivity of Commercially Available Influenza Rapid Diagnostic Tests in the 2018-2019 Influenza Season
    Sakai-Tagawa, Yuko
    Yamayoshi, Seiya
    Kawaoka, Yoshihiro
    FRONTIERS IN MICROBIOLOGY, 2019, 10
  • [10] Duration of fever and symptoms in influenza-infected children treated with baloxavir marboxil during the 2019-2020 season in Japan and detection of influenza virus with the PA E23K substitution
    Wagatsuma, Keita
    Saito, Reiko
    Chon, Irina
    Phyu, Wint Wint
    Fujio, Kakuya
    Kawashima, Takashi
    Sato, Isamu
    Saito, Tadashi
    Minato, Michiyoshi
    Kodo, Naoki
    Suzuki, Eitaro
    Ono, Yasuhiko
    Masaki, Hironori
    Shirahige, Yutaka
    Kitano, Akito
    Hamabata, Hirotsune
    Sun Yuyang
    Li Jiaming
    Watanabe, Hisami
    ANTIVIRAL RESEARCH, 2022, 201